Search

Your search keyword '"Leppä, Sirpa"' showing total 568 results
Start Over Author "Leppä, Sirpa"
568 results on '"Leppä, Sirpa"'

2. Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

Author

Linton, Kim M, Vitolo, Umberto, Jurczak, Wojciech, Lugtenburg, Pieternella J, Gyan, Emmanuel, Sureda, Anna, Christensen, Jacob Haaber, Hess, Brian, Tilly, Hervé, Cordoba, Raul, Lewis, David John, Okada, Craig, Hutchings, Martin, Clausen, Michael Roost, Sancho, Juan-Manuel, Cochrane, Tara, Leppä, Sirpa, Chamuleau, Martine E D, Gernhardt, Diana, Altıntaş, Işıl, Liu, Yan, Ahmadi, Tahamtan, Dinh, Minh H, Hoehn, Daniela, Favaro, Elena, Elliott, Brian, Thieblemont, Catherine, and Vose, Julie M

Published
2024
Full Text
View/download PDF

6. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

Author

Dreyling, Martin, Doorduijn, Jeanette, Giné, Eva, Jerkeman, Mats, Walewski, Jan, Hutchings, Martin, Mey, Ulrich, Riise, Jon, Trneny, Marek, Vergote, Vibeke, Shpilberg, Ofer, Gomes da Silva, Maria, Leppä, Sirpa, Jiang, Linmiao, Stilgenbauer, Stephan, Kerkhoff, Andrea, Jachimowicz, Ron D, Celli, Melania, Hess, Georg, Arcaini, Luca, Visco, Carlo, van Meerten, Tom, Wirths, Stefan, Zinzani, Pier Luigi, Novak, Urban, Herhaus, Peter, Benedetti, Fabio, Sonnevi, Kristina, Hanoun, Christine, Hänel, Matthias, Dierlamm, Judith, Pott, Christiane, Klapper, Wolfram, Gözel, Döndü, Schmidt, Christian, Unterhalt, Michael, Ladetto, Marco, and Hoster, Eva

Published
2024
Full Text
View/download PDF

8. Gut microbiome-derived bacterial extracellular vesicles in patients with solid tumours

Author

Mishra, Surbhi, Tejesvi, Mysore Vishakantegowda, Hekkala, Jenni, Turunen, Jenni, Kandikanti, Niyati, Kaisanlahti, Anna, Suokas, Marko, Leppä, Sirpa, Vihinen, Pia, Kuitunen, Hanne, Sunela, Kaisa, Koivunen, Jussi, Jukkola, Arja, Kalashnikov, Ilja, Auvinen, Päivi, Kääriäinen, Okko-Sakari, Peñate Medina, T., Peñate Medina, O., Saarnio, Juha, Meriläinen, Sanna, Rautio, Tero, Aro, Raila, Häivälä, Reetta, Suojanen, Juho, Laine, Mikael, Erawijattari, Pande Putu, Lahti, Leo, Karihtala, Peeter, Ruuska, Terhi S., and Reunanen, Justus

Published
2023
Full Text
View/download PDF

10. Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL): Results from a phase I/II study.

Author

Bartlett, Nancy L., primary, Dickinson, Michael, additional, Hutchings, Martin, additional, Carlo-Stella, Carmelo, additional, Wu, Shang-Ju, additional, Leppä, Sirpa, additional, Trneny, Marek, additional, Corradini, Paolo, additional, Offner, Fritz, additional, Mulvihill, Estefania, additional, Bottos, Alessia, additional, Chohan, Saibah, additional, Baumlin, Pauline, additional, Relf, James, additional, Lundberg, Linda, additional, and Bachy, Emmanuel, additional

Published
2024
Full Text
View/download PDF

11. Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Author

Meriranta, Leo, Alkodsi, Amjad, Pasanen, Annika, Lepistö, Maija, Mapar, Parisa, Blaker, Yngvild Nuvin, Jørgensen, Judit, Karjalainen-Lindsberg, Marja-Liisa, Fiskvik, Idun, Mikalsen, Lars Tore G., Autio, Matias, Björkholm, Magnus, Jerkeman, Mats, Fluge, Øystein, Brown, Peter, Jyrkkiö, Sirkku, Holte, Harald, Pitkänen, Esa, Ellonen, Pekka, and Leppä, Sirpa

Published
2022
Full Text
View/download PDF

13. Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

Author

Pulczynski, Elisa Jacobsen, primary, Simonsen, Mikkel Runason, additional, Kuittinen, Outi, additional, Fagerli, Unn-Merete, additional, Erlanson, Martin, additional, Fluge, Øystein, additional, Leppä, Sirpa, additional, Østenstad, Bjørn, additional, Fosså, Alexander, additional, Eriksson, Mikael, additional, El-Galaly, Tarec, additional, Kuitunen, Hanne, additional, Papworth, Karin, additional, Ljungqvist, Maria, additional, Pedersen, Martin B., additional, and Pollari, Marjukka, additional

Published
2024
Full Text
View/download PDF

15. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

Author

Mäkisalo, Heikki, Huuhtanen, Riikka, Kosunen, Juhani, Leppä, Sirpa, Bono, Petri, Mattson, Johanna, Österlund, Emerik, Penttinen, Heidi, Mäkelä, Siru, Carpén, Olli, Timonen, Marjut, Lehtomäki, Kaisa, Salminen, Veera, Paunu, Niina, Vornanen, Martine, Lasse, Nieminen, Heervä, Eetu, Korkeila, Eija, Sutinen, Eija, Lavonius, Maija, Sundström, Jari, Mäkinen, Markus, Poussa, Tuija, Uutela, A., Ovissi, A., Hakkarainen, A., Ristimäki, A., Lundbom, N., Kallio, R., Soveri, L.M., Salminen, T., Ålgars, A., Halonen, P., Ristamäki, R., Nordin, A., Blanco Sequeiros, R., Rinta-Kiikka, I., Lantto, E., Virtanen, J., Pääkkö, E., Liukkonen, E., Saunavaara, J., Ryymin, P., Lammentausta, E., Osterlund, P., and Isoniemi, H.

Published
2021
Full Text
View/download PDF

16. Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma : a 10-year follow-up

Author

Pulczynski, Elisa Jacobsen, Simonsen, Mikkel Runason, Kuittinen, Outi, Fagerli, Unn-Merete, Erlanson, Martin, Fluge, Øystein, Leppä, Sirpa, Østenstad, Bjørn, Fosså, Alexander, Eriksson, Mikael, El-Galaly, Tarec, Kuitunen, Hanne, Papworth, Karin, Ljungqvist, Maria, Pedersen, Martin B., Pollari, Marjukka, Pulczynski, Elisa Jacobsen, Simonsen, Mikkel Runason, Kuittinen, Outi, Fagerli, Unn-Merete, Erlanson, Martin, Fluge, Øystein, Leppä, Sirpa, Østenstad, Bjørn, Fosså, Alexander, Eriksson, Mikael, El-Galaly, Tarec, Kuitunen, Hanne, Papworth, Karin, Ljungqvist, Maria, Pedersen, Martin B., and Pollari, Marjukka

Published
2024
Full Text
View/download PDF

17. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE):a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

Author

Dreyling, Martin, Doorduijn, Jeanette, Giné, Eva, Jerkeman, Mats, Walewski, Jan, Hutchings, Martin, Mey, Ulrich, Riise, Jon, Trneny, Marek, Vergote, Vibeke, Shpilberg, Ofer, Gomes da Silva, Maria, Leppä, Sirpa, Jiang, Linmiao, Stilgenbauer, Stephan, Kerkhoff, Andrea, Jachimowicz, Ron D., Celli, Melania, Hess, Georg, Arcaini, Luca, Visco, Carlo, van Meerten, Tom, Wirths, Stefan, Zinzani, Pier Luigi, Novak, Urban, Herhaus, Peter, Benedetti, Fabio, Sonnevi, Kristina, Hanoun, Christine, Hänel, Matthias, Dierlamm, Judith, Pott, Christiane, Klapper, Wolfram, Gözel, Döndü, Schmidt, Christian, Unterhalt, Michael, Ladetto, Marco, Hoster, Eva, Dreyling, Martin, Doorduijn, Jeanette, Giné, Eva, Jerkeman, Mats, Walewski, Jan, Hutchings, Martin, Mey, Ulrich, Riise, Jon, Trneny, Marek, Vergote, Vibeke, Shpilberg, Ofer, Gomes da Silva, Maria, Leppä, Sirpa, Jiang, Linmiao, Stilgenbauer, Stephan, Kerkhoff, Andrea, Jachimowicz, Ron D., Celli, Melania, Hess, Georg, Arcaini, Luca, Visco, Carlo, van Meerten, Tom, Wirths, Stefan, Zinzani, Pier Luigi, Novak, Urban, Herhaus, Peter, Benedetti, Fabio, Sonnevi, Kristina, Hanoun, Christine, Hänel, Matthias, Dierlamm, Judith, Pott, Christiane, Klapper, Wolfram, Gözel, Döndü, Schmidt, Christian, Unterhalt, Michael, Ladetto, Marco, and Hoster, Eva

Abstract

Background: Adding ibrutinib to standard immunochemotherapy might improve outcomes and challenge autologous stem-cell transplantation (ASCT) in younger (aged 65 years or younger) mantle cell lymphoma patients. This trial aimed to investigate whether the addition of ibrutinib results in a superior clinical outcome compared with the pre-trial immunochemotherapy standard with ASCT or an ibrutinib-containing treatment without ASCT. We also investigated whether standard treatment with ASCT is superior to a treatment adding ibrutinib but without ASCT. Methods: The open-label, randomised, three-arm, parallel-group, superiority TRIANGLE trial was performed in 165 secondary or tertiary clinical centres in 13 European countries and Israel. Patients with previously untreated, stage II–IV mantle cell lymphoma, aged 18–65 years and suitable for ASCT were randomly assigned 1:1:1 to control group A or experimental groups A+I or I, stratified by study group and mantle cell lymphoma international prognostic index risk groups. Treatment in group A consisted of six alternating cycles of R-CHOP (intravenous rituximab 375 mg/m2 on day 0 or 1, intravenous cyclophosphamide 750 mg/m2 on day 1, intravenous doxorubicin 50 mg/m2 on day 1, intravenous vincristine 1·4 mg/m2 on day 1, and oral prednisone 100 mg on days 1–5) and R-DHAP (or R-DHAOx, intravenous rituximab 375 mg/m2 on day 0 or 1, intravenous or oral dexamethasone 40 mg on days 1–4, intravenous cytarabine 2 × 2 g/m2 for 3 h every 12 h on day 2, and intravenous cisplatin 100 mg/m2 over 24 h on day 1 or alternatively intravenous oxaliplatin 130 mg/m2 on day 1) followed by ASCT. In group A+I, ibrutinib (560 mg orally each day) was added on days 1–19 of R-CHOP cycles and as fixed-duration maintenance (560 mg orally each day for 2 years) after ASCT. In group I, ibrutinib was given the same way as in group A+I, but ASCT was omitted. Three pairwise o

Published
2024

19. Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Author

Leppä, Sirpa, Jørgensen, Judit, Tierens, Anne, Meriranta, Leo, Østlie, Ingunn, de Nully Brown, Peter, Fagerli, Unn-Merete, Larsen, Thomas Stauffer, Mannisto, Susanna, Munksgaard, Lars, Maisenhölder, Martin, Vasala, Kaija, Meyer, Peter, Jerkeman, Mats, Björkholm, Magnus, Fluge, Øystein, Jyrkkiö, Sirkku, Liestøl, Knut, Ralfkiaer, Elisabeth, Spetalen, Signe, Beiske, Klaus, Karjalainen-Lindsberg, Marja-Liisa, and Holte, Harald

Published
2020
Full Text
View/download PDF

20. Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series

Author

Wise, Jillian F., Nakken, Sigve, Steen, Chloé B., Vodák, Daniel, Trøen, Gunhild, Johannessen, Bjarne, Lingjærde, Ole Christian, Hilden, Vera, Blaker, Yngvild Nuvin, Bai, Baoyan, Aasheim, Lars Birger, Pasanen, Annika, Lorenz, Susanne, Sveen, Anita, Lothe, Ragnhild A., Myklebost, Ola, Leppä, Sirpa, Meza-Zepeda, Leonardo A., Beiske, Klaus, Lawrence, Michael S., Hovig, Eivind, Myklebust, June Helen, Smeland, Erlend B., and Holte, Harald

Published
2020
Full Text
View/download PDF

21. Deep and Durable Responses with Epcoritamab SC Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma: Data from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort

Author

Linton, Kim M, primary, Jurczak, Wojciech, additional, Lugtenburg, Pieternella J., additional, Gyan, Emmanuel, additional, Sureda, Anna, additional, Christensen, Jacob Haaber, additional, Hess, Brian, additional, Tilly, Herve, additional, Cordoba, Raul, additional, Lewis, David John, additional, Okada, Craig, additional, Hutchings, Martin, additional, Clausen, Michael Roost, additional, Vitolo, Umberto, additional, Cochrane, Tara, additional, Leppä, Sirpa, additional, Chamuleau, Martine E.D., additional, Conlon, Rebekah, additional, Favaro, Elena, additional, Favaro, Diana, additional, Altıntaş, Işıl, additional, Liu, Yan, additional, and Thieblemont, Catherine, additional

Published
2024
Full Text
View/download PDF

23. Supplementary table S1 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Author

Monzo, Hector J., primary, Kalander, Kerttu, primary, Hyytiäinen, Marko M., primary, Elbasani, Endrit, primary, Wall, Johanna, primary, Moyano-Galceran, Lidia, primary, Tanjore Ramanathan, Jayendrakishore, primary, Jukonen, Joonas, primary, Laakkonen, Pirjo, primary, Ristimäki, Ari, primary, Carlson, Joseph W., primary, Lehti, Kaisa, primary, Salehi, Sahar, primary, Puolakkainen, Pauli, primary, Haglund, Caj, primary, Seppänen, Hanna, primary, Leppä, Sirpa, primary, and Ojala, Päivi M., primary

Published
2023
Full Text
View/download PDF

24. Data from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Author

Monzo, Hector J., primary, Kalander, Kerttu, primary, Hyytiäinen, Marko M., primary, Elbasani, Endrit, primary, Wall, Johanna, primary, Moyano-Galceran, Lidia, primary, Tanjore Ramanathan, Jayendrakishore, primary, Jukonen, Joonas, primary, Laakkonen, Pirjo, primary, Ristimäki, Ari, primary, Carlson, Joseph W., primary, Lehti, Kaisa, primary, Salehi, Sahar, primary, Puolakkainen, Pauli, primary, Haglund, Caj, primary, Seppänen, Hanna, primary, Leppä, Sirpa, primary, and Ojala, Päivi M., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure Legends from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Author

Monzo, Hector J., primary, Kalander, Kerttu, primary, Hyytiäinen, Marko M., primary, Elbasani, Endrit, primary, Wall, Johanna, primary, Moyano-Galceran, Lidia, primary, Tanjore Ramanathan, Jayendrakishore, primary, Jukonen, Joonas, primary, Laakkonen, Pirjo, primary, Ristimäki, Ari, primary, Carlson, Joseph W., primary, Lehti, Kaisa, primary, Salehi, Sahar, primary, Puolakkainen, Pauli, primary, Haglund, Caj, primary, Seppänen, Hanna, primary, Leppä, Sirpa, primary, and Ojala, Päivi M., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Data S1. from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Author

Monzo, Hector J., primary, Kalander, Kerttu, primary, Hyytiäinen, Marko M., primary, Elbasani, Endrit, primary, Wall, Johanna, primary, Moyano-Galceran, Lidia, primary, Tanjore Ramanathan, Jayendrakishore, primary, Jukonen, Joonas, primary, Laakkonen, Pirjo, primary, Ristimäki, Ari, primary, Carlson, Joseph W., primary, Lehti, Kaisa, primary, Salehi, Sahar, primary, Puolakkainen, Pauli, primary, Haglund, Caj, primary, Seppänen, Hanna, primary, Leppä, Sirpa, primary, and Ojala, Päivi M., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure S5 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Author

Monzo, Hector J., primary, Kalander, Kerttu, primary, Hyytiäinen, Marko M., primary, Elbasani, Endrit, primary, Wall, Johanna, primary, Moyano-Galceran, Lidia, primary, Tanjore Ramanathan, Jayendrakishore, primary, Jukonen, Joonas, primary, Laakkonen, Pirjo, primary, Ristimäki, Ari, primary, Carlson, Joseph W., primary, Lehti, Kaisa, primary, Salehi, Sahar, primary, Puolakkainen, Pauli, primary, Haglund, Caj, primary, Seppänen, Hanna, primary, Leppä, Sirpa, primary, and Ojala, Päivi M., primary

Published
2023
Full Text
View/download PDF

28. IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status

Author

Merryman, Reid W., primary, Belada, David, additional, Sureda, Anna, additional, Leppä, Sirpa, additional, Vermaat, Joost S.P., additional, Holte, Harald, additional, Hutchings, Martin, additional, Lugtenburg, Pieternella, additional, de Vos, Sven, additional, Abrisqueta, Pau, additional, Nijland, Marcel, additional, Christensen, Jacob Haaber, additional, Wahlin, Björn E., additional, Linton, Kim M., additional, Wang, Liwei, additional, Abbas, Aqeel, additional, Rana, Ali, additional, Quadri, Syed, additional, and Falchi, Lorenzo, additional

Published
2023
Full Text
View/download PDF

29. POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status

Author

Merryman, Reid W., primary, Belada, David, additional, Sureda, Anna, additional, Leppä, Sirpa, additional, Vermaat, Joost S.P., additional, Holte, Harald, additional, Hutchings, Martin, additional, Lugtenburg, Pieternella, additional, de Vos, Sven, additional, Abrisqueta, Pau, additional, Nijland, Marcel, additional, Christensen, Jacob Haaber, additional, Wahlin, Björn E., additional, Linton, Kim M., additional, Wang, Liwei, additional, Abbas, Aqeel, additional, Rana, Ali, additional, Quadri, Syed, additional, and Falchi, Lorenzo, additional

Published
2023
Full Text
View/download PDF

32. Pixantrone beyond monotherapy: a review

Author

Barrenetxea Lekue, Cristina, Grasso Cicala, Silvina, Leppä, Sirpa, Stauffer Larsen, Thomas, Herráez Rodríguez , Susana, Alonso Caballero, Clara, Jørgensen, Judit M., Toldbod, Helle, Leal Martínez, Irene, and D’Amore, Francesco

Published
2019
Full Text
View/download PDF

35. Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model

Author

Monzo, Hector J., primary, Kalander, Kerttu, additional, Hyytiäinen, Marko M., additional, Elbasani, Endrit, additional, Wall, Johanna, additional, Moyano-Galceran, Lidia, additional, Tanjore Ramanathan, Jayendrakishore, additional, Jukonen, Joonas J.J., additional, Laakkonen, Pirjo, additional, Ristimäki, Ari, additional, Carlson, Joseph W., additional, Lehti, Kaisa, additional, Salehi, Sahar, additional, Puolakkainen, Pauli, additional, Haglund, Caj, additional, Seppänen, Hanna, additional, Leppä, Sirpa, additional, and Ojala, Päivi M., additional

Published
2023
Full Text
View/download PDF

36. Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas

Author

Leivonen, Suvi-Katri, primary, Friman, Terhi, additional, Autio, Matias, additional, Vaittinen, Samuli, additional, Jensen, Andreas Wind, additional, D’Amore, Francesco, additional, Hamilton-Dutoit, Stephen Jacques, additional, Holte, Harald, additional, Beiske, Klaus, additional, Kovanen, Panu E., additional, Räty, Riikka, additional, and Leppä, Sirpa, additional

Published
2023
Full Text
View/download PDF

41. Subcutaneous Epcoritamab with Rituximab + Lenalidomide in Patients with Relapsed or Refractory Follicular Lymphoma:Phase 1/2 Trial Update

Author

Falchi, Lorenzo, primary, Abrisqueta, Pau, additional, Nijland, Marcel, additional, Leppä, Sirpa, additional, Hutchings, Martin, additional, Holte, Harald, additional, Merryman, Reid W, additional, Lugtenburg, Pieternella, additional, de Vos, Sven, additional, Cheah, Chan Y., additional, Christensen, Jacob Haaber, additional, Arcaini, Luca, additional, Drott, Kristina, additional, Hellström, Mats, additional, Leslie, Lori A., additional, Vitolo, Umberto, additional, Rana, Ali, additional, Abbas, Aqeel, additional, Wang, Liwei, additional, Dinh, Minh, additional, and Belada, David, additional

Published
2022
Full Text
View/download PDF

43. Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial

Author

Jerkeman, Mats, primary, Kolstad, Arne, additional, Hutchings, Martin, additional, Pasanen, Annika, additional, Meriranta, Leo, additional, Niemann, Carsten Utoft, additional, Rask Kragh Jørgensen, Rasmus, additional, El-Galaly, Tarec Christoffer Christoffer, additional, Riise, Jon, additional, Leppä, Sirpa, additional, Christensen, Jacob Haaber, additional, Wader, Karin Fahl, additional, and Glimelius, Ingrid, additional

Published
2022
Full Text
View/download PDF

44. P115: Distinct signaling pathways and checkpoint molecule expression across histological subtypes of nodular lymphocyte-predominant Hodgkin lymphoma

Author

Kalashnikov, Ilja, primary, Kositsky, Rachel, additional, Karjalainen-Lindsberg, Marja-Liisa, additional, Dunkel, Johannes, additional, Pasanen, Annika, additional, Love, Cassandra, additional, Parker, Clay, additional, Ondrejka, Sarah, additional, Hsi, Eric, additional, Juskevicius, Ridas, additional, Evans, Andrew, additional, Evans, Andrew G., additional, Czader, Magdalena, additional, Wang, Lin, additional, Xu, Mina, additional, Paulson, Nathan, additional, Pedersen, Mette ølgod, additional, Ortved Gang, Anne, additional, Koff, Jean, additional, Mccal, Chad, additional, Natkunam, Yaso, additional, Louissaint, Abner, additional, Shin Yeu, Ong, additional, Pillai, Raju, additional, Chapman, Jennifer, additional, Amador, Catalina, additional, Chadburn, Amy, additional, Goswami, Rashmi, additional, Behdad, Amir, additional, Sojitra, Payal, additional, Tse, Eric, additional, Kikkeri, Naresh, additional, Nasresh, Kikkeri N., additional, Fedoriw, Yuri, additional, Dave, Sandeep, additional, and Leppä, Sirpa, additional

Published
2022
Full Text
View/download PDF

46. ABCL-340 Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase 2 Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume

Author

Hutchings, Martin, Carlo-Stella, Carmelo, Morschhauser, Franck, Falchi, Lorenzo, Bachy, Emmanuel, Cartron, Guillaume, Khan, Cyrus, Tani, Monica, Martinez-Lopez, Joaquin, Bartlett, Nancy L., Salar, Antonio, Brody, Joshua, Leppä, Sirpa, Baumlin, Pauline, Mulvihill, Estefania, Relf, James, Xie, Yuying, Kaufman, Derrick, Lundberg, Linda, and Dickinson, Michael

Published
2024
Full Text
View/download PDF

47. Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase 2 Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume

Author

Hutchings, Martin, Carlo-Stella, Carmelo, Morschhauser, Franck, Falchi, Lorenzo, Bachy, Emmanuel, Cartron, Guillaume, Khan, Cyrus, Tani, Monica, Martinez-Lopez, Joaquin, Bartlett, Nancy L., Salar, Antonio, Brody, Joshua, Leppä, Sirpa, Baumlin, Pauline, Mulvihill, Estefania, Relf, James, Xie, Yuying, Kaufman, Derrick, Lundberg, Linda, and Dickinson, Michael

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results